Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: Results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study-Reference-Cited by-同舟云学术

Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: Results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study

Published:2006 Issue:5 Volume:54 Page:1646-1652
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Braun Jürgen,Landewé Robert,Hermann Kay-Geert A.,Han John,Yan Songkai,Williamson Paul,van der Heijde Désirée,

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference30 articles.

1. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors

2. Biological therapies in the spondyloarthritides--the current state

Cited by 200 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The management of axial spondyloarthritis with cutting-edge therapies: advancements and innovations;Expert Opinion on Biological Therapy;2024-08-02

2. Axial spondyloarthritis—current aspects;Exploration of Musculoskeletal Diseases;2024-07-24

3. Looking back on 51 years of the Carol Nachman Prize in Rheumatology—significance for the field of spondyloarthritis research;Zeitschrift für Rheumatologie;2024-06-12

4. Treatment overview of axial spondyloarthritis in 2023;Best Practice & Research Clinical Rheumatology;2023-09

5. Do fatty lesions explain the effect of inflammation on new syndesmophytes in patients with radiographic axial spondyloarthritis? Results from the SIAS cohort and ASSERT trial;RMD Open;2023-07